Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideJNJJohnson & Johnson
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | JNJ | TMO |
|---|
| Close | 273.20 | 697.00 |
| Market Cap | $666B | $258B |
| 1M | +3.20% | +3.25% |
| P/E (TTM) | 41.3 | 36.4 |
| Forward P/E | 22.0 | 24.6 |
| P/E 5-Yr Percentile | 100 | 78 |
| P/S | 6.7 | 5.4 |
| P/B | 7.8 | 4.7 |
| Dividend Yield | 3.12% | 0.29% |
| Latest Quarter Revenue | $25.4B | $12.1B |
| Revenue YoY | +5.9% | +9.1% |
| Gross Margin | 68.1% | — |
| Latest Quarter EPS | 0.09 | 4.64 |
| Avg Post-Earnings Move | ±0.6% | ±1.2% |
| EPS Beat Rate | 1 / 1 | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 1.18% | 1.82% |
| 90-Day Net Insider Buying | −$62.0M | −$40.3M |
JNJ · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
